What is AngioDynamics's EV / sales?

AngioDynamics (ANGO) reported EV / sales of 1.4× in Q4 2025.

How has AngioDynamics's EV / sales changed year-over-year?

AngioDynamics's EV / sales increased by 17.9% year-over-year, from 1.2× to 1.4×.

What is the long-term trend for AngioDynamics's EV / sales?

Over 4 years (2021 to 2025), AngioDynamics's EV / sales has grown at a -20.2% compound annual growth rate (CAGR), from 2.9× to 1.2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

AngioDynamics ANGO EV / sales

EV / sales at other companies

AbbottABT

4.6×-1.0×

Becton, Dickinson and CompanyBDX

2.7×-1.4×

TFX

TeleflexTFX

3.6×-1.0×

StrykerSYK

5.4×-1.3×

Merit Medical SystemsMMSI

2.9×-1.9×

ICU MedicalICUI

2×0.0×

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

enterprise value/total revenue=1.4×

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's EV / sales?: AngioDynamics (ANGO) reported EV / sales of 1.4× in Q4 2025.
How has AngioDynamics's EV / sales changed year-over-year?: AngioDynamics's EV / sales increased by 17.9% year-over-year, from 1.2× to 1.4×.
What is the long-term trend for AngioDynamics's EV / sales?: Over 4 years (2021 to 2025), AngioDynamics's EV / sales has grown at a -20.2% compound annual growth rate (CAGR), from 2.9× to 1.2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.